Malignant Melanoma Metastasis - Medical Algorithm

Evaluation

Are you evaluating a patient with a primary cutaneous malignant melanoma?

Yes

Maximal vertical thickness of the primary tumor in the histologic sections

Was the primary tumor ulcerated?

Yes

Have the regional lymph nodes been biopsied?

Yes

Is metastatic melanoma seen in the lymph nodes?

Yes

Primary site of the melanoma

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

E score

Pretest probability for metastasis to lymph nodes

Estimated 10 year survival rate

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
- N-SNORE Scoring System of Murali et al for Predicting Risk of Non-Sentinel Lymph Node Positivity for a Patient with Cutaneous Malignant Melanoma
Clinical Diagnosis, Including Family History For Genetics
- ABCDEF Rule of Levit et al for Detection of Subungual Melanoma
Criteria For Diagnosis
- ABCDEF Rule of Levit et al for Detection of Subungual Melanoma
Severity, Prognosis, Stage
- N-SNORE Scoring System of Murali et al for Predicting Risk of Non-Sentinel Lymph Node Positivity for a Patient with Cutaneous Malignant Melanoma
- Clark Levels for Cutaneous Malignant Melanoma

Specialty

Hematology Oncology
Surgery, general
Dermatology

Objective

risk factors
severity
prognosis
stage

ICD-10

C43 - Malignant melanoma of skin

Model of Vollmer et al for Predicting Pretest Probability of Metastatic Cutaneous Malignant Melanoma to Lymph Nodes

Purpose: To estimate the risk of lymph node metastasis in a patient with a primary cutaneous malignant melanoma using the model of Vollmer et al.